Understand the source comparison
How to Lose Weight Fast with Peptides: Protocol Comparison
Semaglutide (GLP-1 only) 0.25mg weekly 2.4mg weekly 16–20 weeks 14.9% mean body weight 30–40% during titration Metabolically healthy individuals seeking appetite regulation Tirzepatide (GLP-1/GIP dual) 2.5mg weekly 15mg weekly 20 weeks 20.9% mean body weight 4
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semaglutide (GLP-1 only)
- 0.25mg weekly
- 2.4mg weekly
- 16–20 weeks
- 14.9% mean body weight
- 30–40% during titration
- Metabolically healthy individuals seeking appetite regulation
- Tirzepatide (GLP-1/GIP dual)
- 2.5mg weekly
- 15mg weekly
- 20 weeks
- 20.9% mean body weight
- 40–50% during titration
- Individuals with insulin resistance, prediabetes, or type 2 diabetes
- Compounded Semaglutide
- Equivalent to branded (same molecule)
- Cost-conscious patients; same mechanism as branded product
- Research Peptides (e.g., Survodutide)
- Varies by compound
- Study-dependent
- Pre-clinical; efficacy under investigation
- Not yet characterized in humans
- Researchers investigating novel GLP-1/glucagon dual agonists